We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Untreated jaundice in infants can result in the rare but dangerous consequence of kernicterus. Excess bilirubin harms the brain or central nervous system, which is the cause of the condition.
Jaundice affects 60 to 80 percent of newborns worldwide. In wealthy countries, only 0.4 to 2.7 out of every 100,000 children get kernicterus or acute bilirubin encephalopathy. When bilirubin levels rise to this point, they spread to the brain and damage the CNS’s tissues. At the moment, “kernicterus” describes severe neurological damage brought on by jaundice. Nonetheless, any damage brought on by severe jaundice is also considered to be a type or stage of kernicterus.
High bilirubin levels in a newborn’s blood can cause kernicterus, a kind of brain injury. Infants with severe, untreated jaundice are commonly linked to the illness. Athetoid cerebral palsy and hearing loss might develop. Kernicterus may cause dental and visual issues in addition to brain deficiencies. Kernicterus can be avoided with early diagnosis and treatment of jaundice.
Bilirubin can pass the thin tissue barrier separating the brain and blood in newborns with extremely high blood bilirubin levels (hyperbilirubinemia) (the blood-brain barrier).
The brain and spinal cord can suffer life-threatening damage from bilirubin.
Bilirubin encephalopathy is another name for brain damage brought on by excessive amounts of bilirubin.
According to Data Bridge Market Research, at a CAGR of 2.50% from 2023 to 2030, the kernicterus treatments market, which is now valued at USD 2.86 billion in 2022, is anticipated to grow to USD 3.48 billion by 2030. The market reports compiled by Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. These insights on market scenarios include market value, growth rate, segmentation, geographic coverage, and major players.
For more information about kernicterus treatment market visit
https://www.databridgemarketresearch.com/reports/global-kernicterus-treatment-market
Leading market research company Data Bridge Market Research provides customers with meticulous industry knowledge for the growth of their businesses. Reputable academic institutions, start-ups, and businesses utilize the reports and services provided by Data Bridge Market Research to monitor and comprehend the shifting regional and worldwide business environments.
The confidence our clients’ and customers’ have in our products and services has encouraged us to consistently provide the best. They have received advice for effective decision-making and corporate expansion plans thanks to our cutting-edge research solutions.
Notifications